ZYZhilong Yan

Zhilong Yan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhilong Yan has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Li Hong

    Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

    3 shared publications
  • Zhiyan Zhan

    Department of Clinical Nutrition, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

    2 shared publications
  • Bing Zhang

    Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350014, China

    1 shared publication
  • Bing Zhang

    Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350014, China

    1 shared publication
  • Fei Chen

    Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350014, China

    1 shared publication
  • Guoqiang Li

    Department of Medical Genetics and Molecular Diagnostic Laboratory, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

    1 shared publication

Latest Publications

  • Open Access

    ApoE and Fibroblast–Macrophage Interaction in the Aganglionic Segment of Hirschsprung’s Disease-Associated Enterocolitis

    by Qihui Shao, Zhulin Wang, Yifan Fang, Jing Li, Wenxi Zhu, Bing Zhang, Fei Chen, Zhilong Yan, Zhiyan Zhan, Li Hong

    Background: The pathogenesis of Hirschsprung’s disease-associated enterocolitis (HAEC) remains unclear. Currently, no definitive studies have elucidated the communication between intestinal macrophages and fibroblasts during the development of HAEC, nor their specific functional roles in this process. Methods: The first step is utilizing single-cell transcriptomics and spatial transcriptomic sequencing techniques to validate the phenotypes and corresponding spatial location characteristics of intestinal fibroblasts in the patient with HAEC. The second is verifying the mechanism whereby specific subtypes of fibroblasts and macrophages communicate via apolipoprotein E (ApoE) and modulate corresponding inflammatory pathways using co-culture, Western blot and other molecular biology techniques. Results: As HAEC progressed, JUN expression was significantly upregulated in CTHRC1+PRRX1+ fibroblasts enriched in the submucosal layer in the aganglionic segment. In vitro experiments showed JUN-overexpressing 3T3-L1 cells exhibited increased ApoE secretion. ApoE may interact with macrophages and potentially suppress their inflammation through the p38/MAPK and NF-κB pathways. Conclusions:CTHRC1+PRRX1+ fibroblasts and ApoE may represent a potential mechanistic target for future investigation into inhibiting the progression of the aganglionic segment in HAEC and treating colitis.

  • Open Access

    Compact Gut Microbial Dysbiosis Signature Associated with Necrotizing Enterocolitis and Altered Early Microbiota Development

    by Ying Xiang, Zhuoqi Zhao, Zhong Feng, Jialu Zhuang, Yu Chen, Yansong Chen, Shumin Feng, Liya Pan, Zhilong Yan, Li Hong

    Background: Necrotizing enterocolitis (NEC) is a life-threatening intestinal disorder in preterm infants and is strongly associated with gut microbial dysbiosis. However, whether recurrent genus-level dysbiosis patterns can be observed across heterogeneous NEC cohorts and summarized as a compact, interpretable microbial signature remains unclear. Methods: We analyzed two public neonatal gut microbiome cohorts and an independent real-world cohort within a three-stage framework of discovery, contextual analysis, and external validation. Community composition, alpha diversity, beta diversity, and differential genera were evaluated using harmonized genus-level features within each cohort. Machine learning feature prioritization was used to derive a reduced NEC-associated microbial signature. A four-group cohort was then used to examine this signature in relation to disease status, antibiotic exposure, and early postnatal development. The reduced signature was finally examined in our collected samples. Results: NEC-related microbial alterations showed marked heterogeneity at the whole-community level across cohorts, whereas several genus-level directional patterns recurred across datasets. Across datasets, NEC was repeatedly associated with enrichment of several opportunistic genera, including Enterobacter, Klebsiella, Serratia, and Escherichia–Shigella, and depletion of commensal or probiotic-associated taxa such as Bifidobacterium, Lactobacillus, and Pediococcus. Feature prioritization yielded a compact microbial signature that improved discrimination over the unfiltered abundance profile in the discovery cohort (AUC 0.674 vs. 0.59). In the four-group cohort, the NEC_ABT group remained distinct from healthy controls, supporting partial modification rather than normalization of the NEC-associated pattern. In our collected samples, the signature retained directional consistency but showed only modest external discrimination (AUC 0.618). Conclusions: These findings identify recurrent genus-level dysbiosis features associated with NEC across clinically heterogeneous settings. The compact microbial signature may serve as an exploratory biomarker for longitudinal and mechanistic validation, but not as a standalone diagnostic tool.

  • Open Access

    The Trim32-DPEP2 axis is an inflammatory switch in macrophages during intestinal inflammation

    by Zhiyan Zhan, Huisheng Liang, Zhuoqi Zhao, Liya Pan, Jing Li, Yuyun Chen, Zhoulonglong Xie, Zhilong Yan, Ying Xiang, Wenxue Liu, et al.

    The mechanisms via which inflammatory macrophages mediate intestinal inflammation are not completely understood. Herein, using merged analysis of RNA sequencing and mass spectrometry-based quantitative proteomics, we detected differences between proteomic and transcriptomic data in activated macrophages. Dipeptidase-2 (DPEP2), a member of the DPEP family, was highly expressed and then downregulated sharply at the protein level but not at the mRNA level in macrophages in response to inflammatory stimulation. Suppression of DPEP2 not only enhanced macrophage-mediated intestinal inflammation in vivo but also promoted the transduction of inflammatory pathways in macrophages in vitro. Mechanistically, overexpressed DPEP2 inhibited the transduction of inflammatory signals by resisting MAK3K7 in inactivated macrophages, whereas DPEP2 degradation by activated Trim32 resulted in strong activation of NF-κB and p38 MAPK signaling via the release of MAK3K7 in proinflammatory macrophages during the development of intestinal inflammation. The Trim32-DPEP2 axis accumulates the potential energy of inflammation in macrophages. These results identify DPEP2 as a key regulator of macrophage-mediated intestinal inflammation. Thus, the Trim32-DPEP2 axis may be a potential therapeutic target for the treatment of intestinal inflammation.


  • Open Access

    Concurrent somatic KRAS mutation and germline 10q22.3-q23.2 deletion in a patient with juvenile myelomonocytic leukemia, developmental delay, and multiple malformations: a case report

    by Ruen Yao, Tingting Yu, Yufei Xu, Guoqiang Li, Lei Yin, Yunfang Zhou, Jian Wang, Zhilong Yan

    The proto-oncogene KRAS performs an essential function in normal tissue signaling, and the mutation of KRAS gene is a key step in the development of many cancers. Somatic KRAS mutations are often detected in patients with solid and non-solid tumors, whereas germline KRAS mutations are implicated in patients with the Noonan syndrome, cardio-facio-cutaneous (CFC) syndrome and Costello syndrome. The deletion of chromosome 10q22.3-q23.2 is a rare cytogenetic abnormality, which often leads to distinct facial appearance and delays in speech and global development. Herein, we report the case of a 4-year-old boy diagnosed with juvenile myelomonocytic leukemia. The boy also had syndromic features, such as speech and motor developmental delay, multiple congenital malformations, including distinct facial features, club feet, and cryptorchidism. Using whole-exome sequencing, we identified a pathogenic mutation in KRAS [c.34G > A, p.Gly12Ser] isolated from peripheral blood DNA. Sanger sequencing confirmed the wild-type sequence in the parents and patient’s salivary cell DNA indicating its somatic state. A 7311-kb deletion in 10q22.3-q23.2 was also revealed by chromosomal microarray analysis, which was later proved as a germline de novo variant. Juvenile myelomonocytic leukemia in the patient was attributed to a somatic KRAS mutation, whereas the syndromic features of the patient were considered a consequence of germline chromosome 10q22.3-q23.2 deletion. Genetic testing for patients with complicated phenotypes can be valuable in detecting multiple pathogenic variants.


  • Collis 联合胃底折叠术治疗儿童先天性食管下段狭窄二例

    by 昱梅 董, 龙严 志

    总结 Collis 联合胃底折叠术治疗 2 例儿童先天性食管下段狭窄的诊治体会。 2015 年 12 月及 2016 年 6 月收治 2 例先天性食管下段狭窄男性患儿,年龄均为 2 岁;均有反复呕吐史,伴营养不良。其中 1 例因重度营养不良行胃造瘘术,8 个月后行该次手术。术前 2 例均行食管下端球囊扩张 1 次无效。行 Collis 术联合胃底折叠术,同时行幽门成形。 2 例手术均顺利完成,手术时间分别为 120、180 min,术中出血量 15、20 mL。狭窄段组织病理检查提示为异位气管支气管软骨。术后 1 周上消化道造影示吻合口无狭窄及漏,无明显胃食管反流。2 例患儿均获随访,均开始进普食,无吞咽困难;体质量较术前明显增加。术后 6 个月上消化道造影检查示吻合口通畅。 Collis 联合胃底折叠术是治疗儿童先天性食管下段狭窄的一种较好方法,合理的手术方案设计和手术精细化操作,可以减少术后并发症。